First Light Asset Management, LLC Harvard Bioscience Inc Transaction History

First Light Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$1.59 - $3.47 $935,155 - $2.04 Million	-588,148 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$1.93 - $4.59 $12.5 Million - $29.8 Million	-6,482,090 Reduced 91.68%	588,148 $1.18 Million
Q1 2019 May 15, 2019	BUY	$2.77 - $4.38 $168,006 - $265,655	60,652 Added 0.87%	7,070,238 $30.5 Million
Q4 2018 Feb 14, 2019	BUY	$3.03 - $5.0 $2.24 Million - $3.7 Million	739,471 Added 11.79%	7,009,586 $22.3 Million
Q3 2018 Nov 14, 2018	BUY	$5.0 - $6.65 $1.6 Million - $2.12 Million	319,101 Added 5.36%	6,270,115 $32.9 Million
Q2 2018 Aug 14, 2018	BUY	$4.2 - $5.95 $2.14 Million - $3.03 Million	509,724 Added 9.37%	5,951,014 $31.8 Million
Q1 2018 May 15, 2018	BUY	$3.3 - $5.15 $2.65 Million - $4.13 Million	802,639 Added 17.3%	5,441,290 $27.2 Million
Q4 2017 Feb 14, 2018	BUY	$3.08 - $3.8 $1.61 Million - $1.99 Million	522,369 Added 12.69%	4,638,651 $15.3 Million
Q3 2017 Nov 14, 2017	BUY	$2.7 - $3.75 $1.47 Million - $2.04 Million	544,086 Added 15.23%	4,116,282 $15.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	3,572,196	3,572,196 $9.11 Million

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.